HuGE Literature Finder
Records
1
-
30
| Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer. Scientific reports 2021 Oct 11 (1): 19596. Cho Su Han, Yoon Shinkyo, Lee Dae Ho, Kim Sang-We, Kim Kwone |
| PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort. Clinical lung cancer 2021 Aug . Jin Yan, Xue Qianqian, Shen Xuxia, Zheng Qiang, Chen Haiquan, Zhou Xiaoyan, Li Yu |
| Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases. Clinical neurology and neurosurgery 2021 Jul 208 106841. Hanke Benjamin, Jünger Stephanie T, Kirches Elmar, Waldt Natalie, Schreiber Jens, Lücke Eva, Franke Sabine, Sandalcioglu I Erol, Warnke Jan-Peter, Meisel Hans-Jörg, Prell Julian, Scheller Christian, Braunsdorf Werner E K, Preusser Matthias, Schildhaus Hans-Ulrich, Mawrin Christi |
| Relationship between clinical features and gene mutations in non-small cell lung cancer with osteoblastic bone metastasis. Cancer treatment and research communications 2021 Jul 28 100440. Takahara Yutaka, Nakase Keisuke, Nojiri Masafumi, Kato Ryo, Shinomiya Shohei, Oikawa Taku, Mizuno Shi |
| Retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients. Asian journal of surgery 2021 Jul . Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij |
| Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces. Annals of translational medicine 2021 Jun 9 (12): 985. Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu |
| Cell-Free Circulating Tumor DNA Improves Standard Genotyping of Non-Small-Cell Lung Cancer and Increases Detection of Targetable Alterations in a Selected Hispanic Cohort. Oncology 2021 Apr 1-8. Zatarain-Barrón Zyanya Lucia, Cardona Andrés F, Díaz-García Diego, Trejo Rosales Rogelio, Rojas Leonardo, Cruz-Rico Graciela, Nagy Rebecca, Cabrera Luis, Vargas Carlos, Saam Jennifer, Barrón Feliciano, Arrieta Osc |
| Integration of comprehensive genomic profiling, tumor mutational burden, and PD-L1 expression to identify novel biomarkers of immunotherapy in non-small cell lung cancer. Cancer medicine 2021 Apr 10 (7): 2216-2231. Shi Yunfei, Lei Youming, Liu Li, Zhang Shiyue, Wang Wenjing, Zhao Juan, Zhao Songhui, Dong Xiaowei, Yao Ming, Wang Kai, Zhou Qi |
| Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical field. Lung cancer (Amsterdam, Netherlands) 2021 Apr 154 131-141. Volckmar Anna-Lena, Christopoulos Petros, Kirchner Martina, Allgäuer Michael, Neumann Olaf, Budczies Jan, Rempel Eugen, Horak Peter, Glade Julia, Goldschmid Hannah, Seker-Cin Huriye, Brandt Regine, Kriegsmann Mark, Leichsenring Jonas, Winter Hauke, Faehling Martin, Fischer Jürgen R, Heußel Claus Peter, Herth Felix, Brummer Tilman, Fröhling Stefan, Schirmacher Peter, Thomas Michael, Endris Volker, Penzel Roland, Kazdal Daniel, Bochtler Tilmann, Stenzinger Albrec |
| The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients. International journal of cancer 2021 Apr . Cai Lei, Chen Yong, Tong Xiaoling, Wu Xue, Bao Hua, Shao Yang, Luo Zhuang, Wang Xuming, Cao Ya |
| Crizotinib in Patients With MET-Amplified NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Mar . Camidge D Ross, Otterson Gregory A, Clark Jeffrey W, Ignatius Ou Sai-Hong, Weiss Jared, Ades Steven, Shapiro Geoffrey I, Socinski Mark A, Murphy Danielle A, Conte Umberto, Tang Yiyun, Wang Sherry C, Wilner Keith D, Villaruz Liza |
| Morphological and genetic heterogeneity of synchronous multifocal lung adenocarcinoma in a Chinese cohort. BMC cancer 2021 Feb 21 (1): 176. Zhu Donglin, Cao Dan, Shen Minghong, Lv Jinghu |
| Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China. Frontiers in oncology 2021 11 630717. Lv Weize, Cheng Hua, Shao Di, Wei Yajun, Zhu Weiping, Wu Kui, Jiang Wenxi, Hu Liyang, Sha Zhou, Zhong Beilong, Pei Xiaofe |
| Early Blood-based Liquid Biopsy in Patients with Treatment-naïve Metastatic Adenocarcinoma of the Lung: A Case Series. The Israel Medical Association journal : IMAJ 2020 Dec 22 (12): 784-787. Peled Michael, Bar Jair, Avni Liat, Chatterji Sumit, Somech Dafna, Dvir Addie, Soussan-Gutman Lior, Onn Am |
| The landscape of kinase domain duplication in Chinese lung cancer patients. Annals of translational medicine 2020 Dec 8 (24): 1642. Wu Di, Xie Yuancai, Jin Chang'e, Qiu Jinfan, Hou Ting, Du Haiwei, Chen Songan, Xiang Jianxing, Shi Xi, Liu Junli |
| Multiple combination therapy based on intrathecal pemetrexed in non-small cell lung cancer patients with refractory leptomeningeal metastasis. Annals of palliative medicine 2020 Nov 9 (6): 4233-4245. Miao Qian, Zheng Xiaobin, Zhang Longfeng, Jiang Kan, Wu Biao, Lin G |
| EGFR mutations and ROS1 and ALK rearrangements in a large series of non-small cell lung cancer in South India. Cancer reports (Hoboken, N.J.) 2020 Sep e1288. Tarigopula Anil, Ramasubban Gayathri, Chandrashekar Vani, Govindasami Perumal, Chandran Chit |
| Molecular and clinicopathological characteristics of ROS1-rearranged non-small-cell lung cancers identified by next-generation sequencing. Molecular oncology 2020 Sep . Cui Meiying, Han Yuchen, Li Pan, Zhang Jianying, Ou Qiuxiang, Tong Xiaoling, Zhao Ruiying, Dong Nan, Wu Xue, Li Wencai, Jiang Guozho |
| Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients. European review for medical and pharmacological sciences 2020 Jul 24 (14): 7664-7672. Zhang H, Deng Y-M, Chen Z-C, Tang Y-C, Yang S, Zhang S-D, Liang J-M, Wang Y-G, Wu X, Zhang R-W, Feng W |
| Status of 10 targeted genes of non-small cell lung cancer in eastern China: A study of 884 patients based on NGS in a single institution. Thoracic cancer 2020 Jul . Li Dan, Ding Li, Ran Wenwen, Huang Yan, Li Guangqi, Wang Chengqin, Xiao Yujing, Wang Xiaonan, Lin Dongliang, Xing Xiaomi |
| Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases. Cancer 2020 May . Mack Philip C, Banks Kimberly C, Espenschied Carin R, Burich Rebekah A, Zill Oliver A, Lee Christine E, Riess Jonathan W, Mortimer Stefanie A, Talasaz AmirAli, Lanman Richard B, Gandara David |
| ALK and ROS1 rearrangement tested by ARMS-PCR in non-small-cell lung cancer patients via cytology specimens: The experience of Shanghai Pulmonary Hospital. Diagnostic cytopathology 2020 Mar . Cao Ziyang, Wu Wei, Zhang Wei, Li Zhixin, Gao Caixia, Huang Yan, Zhang Lipi |
| Actionable Mutation Profiles of Non-Small Cell Lung Cancer patients from Vietnamese population. Scientific reports 2020 Feb 10 (1): 2707. Dang Anh-Thu Huynh, Tran Vu-Uyen, Tran Thanh-Truong, Thi Pham Hong-Anh, Le Dinh-Thong, Nguyen Lam, Nguyen Ngoc-Vu, Thi Nguyen Thai-Hoa, Nguyen Chu Van, Le Ha Thu, Thi Nguyen Mai-Lan, Le Vu Thuong, Nguyen Phuc Huu, Vo Binh Thanh, Thi Dao Hong-Thuy, Nguyen Luan Thanh, Van Nguyen Thien-Chi, Bui Quynh-Tram Nguyen, Nguyen Long Hung, Nguyen Nguyen Huu, Thi Nguyen Quynh-Tho, Le Truong Xuan, Do Thanh-Thuy Thi, Dinh Kiet Truong, Do Han Ngoc, Phan Minh-Duy, Nguyen Hoai-Nghia, Tran Le Son, Giang H |
| Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China. Clinical lung cancer 2020 Feb . Zhao Yiming, Dong Yu, Zhao Ruiying, Zhang Bo, Wang Shuyuan, Zhang Lele, Hu Minjuan, He Qingnan, Zhang Wei, Han Baoh |
| Correlation between combining F-FDG PET/CT metabolic parameters and other clinical features and ALK or ROS1 fusion in patients with non-small-cell lung cancer. European journal of nuclear medicine and molecular imaging 2020 Jan . Ruan Maomei, Liu Liu, Wang Lihua, Lei Bei, Sun Xiaoyan, Chang Cheng, Shen Yan, Xie Wenh |
| Efficacy and safety of programmed cell-death-protein-1 and its ligand inhibitors in pretreated patients with epidermal growth-factor receptor-mutated or anaplastic lymphoma kinase-translocated lung adenocarcinoma. Medicine 2020 Jan 99 (3): e18726. Bylicki Olivier, Guisier Florian, Monnet Isabelle, Doubre Hélène, Gervais Radj, Janicot Henri, Perol Maurice, Fournel Pierre, Lamy Régine, Auliac Jean-Bernard, Chouaid Christ |
| Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer. Journal of oncology 2020 2020 8811487. Chen Dongfang, Xu Jianlin, Qiao Rong, Zhao Yizhuo, Chu Tianqing, Han Baohui, Zhong Run |
| Detection of Targetable Genetic Alterations in Korean Lung Cancer Patients: A Comparison Study of Single-Gene Assays and Targeted Next-Generation Sequencing. Cancer research and treatment : official journal of Korean Cancer Association 2019 Nov . Park Eunhyang, Shim Hyo S |
| Molecular profiling in lung cancer associated with cystic airspaces. Acta clinica Belgica 2019 Oct 1-4. Snoeckx Annemiek, Reyntiens Pieter, Pauwels Patrick, Van Schil Paul E, Parizel Paul M, Van Meerbeeck Jan |
| Efficacy and safety of crizotinib in patients with ROS1 rearranged non-small cell lung cancer: a retrospective analysis. Journal of thoracic disease 2019 Jul 11 (7): 2965-2972. Masuda Ken, Fujiwara Yutaka, Shinno Yuki, Mizuno Takaaki, Sato Jun, Morita Ryo, Matsumoto Yuji, Murakami Shuji, Goto Yasushi, Kanda Shintaro, Horinouchi Hidehito, Yamamoto Noboru, Ohe Yuichi |
- Page last reviewed:Oct 1, 2021
- Page last updated:Oct 20, 2021
- Content source: